GLP-1 Maintenance Dosing: Can You Keep the Weight Off on Less Medication?
The Bag Blogs · Wellness Education · From the Clinicians
The Short Answer
A small 2026 study in the journal Obesity followed 30 adults who had stopped losing weight on weekly semaglutide or tirzepatide, then stretched their dosing to about every other week (and sometimes longer) for roughly 36 weeks on average. As a group, they kept their weight loss and their metabolic gains. But it was a small case series with no comparison group, and larger randomized trials show that stopping, or cutting the dose too far, often lets weight creep back.
The takeaway is not "take less." It is "find the lowest dose that works for you, then keep revisiting it with a clinician." That is how we approach GLP-1 care at Bag Bar in Monmouth County, NJ.
Book your Metabolic Reset consult
The goal is never the biggest dose. It is the smallest dose that gets you there and keeps you there.
Most people start a GLP-1 asking, "How fast can I lose the weight?" The question we care about just as much is the one nobody asks on day one: "What will it take to keep it off, and what is the least medication I need to do that?"
A new study out of Scripps Clinic in California gave that second question some long-overdue attention, and JAMA Network took notice. Here is what it found, what it did not prove, and how we think about it.
What did the new GLP-1 maintenance study find?
Researchers at Scripps Clinic (Wong, Wu, Garhe and Biermann, Obesity, 2026) reviewed the charts of 30 adults, 21 taking tirzepatide and 9 taking semaglutide, who had hit a weight plateau on standard weekly doses. Their clinicians moved them to less frequent dosing: usually about every other week, and for a few patients as rarely as once every six weeks. The average time on the reduced schedule was about 36 weeks. Here is how they did:
- Weight: Average weight at the plateau was 74.1 kg (about 163 lb). During the reduced-frequency period it averaged 72.4 kg (about 160 lb), a further drop of roughly 2%.
- Body composition: Body fat kept declining while skeletal muscle mass stayed stable, which matters because protecting muscle is a core goal of good weight-loss care.
- Metabolic health: Gains held. According to Scripps, HDL ("good") cholesterol improved significantly, triglycerides improved slightly, and A1c and blood pressure were unchanged on average.
As one of the authors has pointed out, once a plateau is reached there is no established protocol for a reduced dosing schedule. That gap is exactly why this study is interesting.
The other side: why this is not a green light to cut your dose
We hold ourselves to a simple rule: if the evidence has a catch, you hear about it. Here are the catches.
- It is small and retrospective. Thirty people, looked at after the fact, with no comparison group and no blinding. The authors acknowledge possible selection bias (people who step down may be more motivated) and call for larger randomized trials.
- It did not work for everyone. According to Scripps, four additional patients who tried stretching their doses regained some weight and returned to weekly dosing.
- Stopping tells a different story. In the STEP 1 extension, people who stopped semaglutide regained about two thirds of the weight they had lost within a year. In SURMOUNT-4, people switched from tirzepatide to placebo regained about 14% of their body weight, while those who stayed on treatment lost another 5.5%.
- A lower dose is not the same as a longer interval. In the 2026 SURMOUNT-MAINTAIN trial, published in The Lancet, people stepped down to a lower weekly dose kept more weight off than those switched to placebo, but regained more than those who stayed on the maximum dose. The best maintenance strategy likely differs from person to person. (This trial was funded by the drug's manufacturer.)
- These studies used FDA-approved products, and reduced-frequency dosing is not an FDA-approved schedule. It is an emerging idea, not a standard of care.
What this means for you: the Bag Bar approach
"Personalized" gets thrown around a lot. In obesity medicine it is not a slogan. People differ in appetite biology, side-effect tolerance, other medications and goals. Our Metabolic Reset program is built on three ideas:
- Start low, go slow, and stop climbing when it works. We increase gradually and aim for the lowest effective dose that moves you toward your goal, rather than pushing to the maximum by default. Slower steps also tend to mean fewer stomach side effects.
- Side effects are information, not something to tough out. Nausea, constipation and reflux are signals to adjust dose, timing or food strategy. Because we come to you, check-ins fit into your real life.
- Plan the maintenance phase from day one. When you reach your goal and plateau, we review whether a lower dose or a longer interval is reasonable, using your weight trend, labs and how you feel, and we change one thing at a time. If weight starts to creep back, we adjust early. Some patients will need steady, ongoing dosing, much like blood pressure medication, and that is not a failure.
Medication works best alongside the basics: enough protein, strength training to protect muscle, and sleep. Our goal is simple to say and hard to do: help you reach your goal weight on the lowest dose with the fewest side effects, then hold it there on the lowest dose that works. We cannot promise every patient can step down, and no honest clinic can. We can promise that we will keep asking the question.
Is a GLP-1 right for you? Safety first
GLP-1 medications are not for everyone. They are not appropriate for people with a personal or family history of medullary thyroid carcinoma or MEN 2, or for anyone who is pregnant or planning pregnancy. Common side effects include nausea, vomiting, diarrhea and constipation. Less common but serious risks include pancreatitis and gallbladder problems. Every Bag Bar patient is screened by a licensed PA-C, with physician medical director oversight. Please never change your dose or interval on your own.
Disclosure: The studies discussed above used FDA-approved semaglutide and tirzepatide products. Bag Bar's Metabolic Reset program uses compounded medications prepared by licensed 503A and 503B pharmacies. Compounded drugs are not FDA-approved, and the FDA does not review them for safety, effectiveness or quality before they are dispensed. Compounding pharmacies are still closely regulated: 503A pharmacies are licensed and inspected by state boards of pharmacy, and 503B outsourcing facilities are registered with and inspected by the FDA and must meet federal manufacturing quality standards. Compounded medication is prescribed only to patients who meet clinical requirements after an evaluation by a licensed clinician.
Where can I get a GLP-1 consult in Monmouth County, NJ?
Bag Bar is a PA-C-owned mobile concierge wellness company based in Red Bank. We bring Metabolic Reset consults and follow-up care to your home, office or event in Red Bank, Rumson, Little Silver, Fair Haven, Colts Neck, Holmdel and across Monmouth County. Your $150 consultation is credited toward your first month. See the full menu or reserve your visit below.
GLP-1 Maintenance Dosing FAQ
Can you take less GLP-1 medication and keep the weight off?
Possibly, for some people, but it is not proven for everyone. A 2026 case series in Obesity followed 30 adults who had reached a plateau on weekly semaglutide or tirzepatide and then stretched dosing to about every other week. On average they kept their weight loss and metabolic improvements. The study was small and had no comparison group, and larger trials show that stopping or cutting the dose too far often leads to weight regain. Any change should be made with a clinician, never on your own.
What happens if I stop semaglutide or tirzepatide?
In clinical trials, most people regain a significant share of the weight. In the STEP 1 extension, participants regained about two thirds of their lost weight within a year of stopping semaglutide. In SURMOUNT-4, people switched from tirzepatide to placebo regained about 14% of their body weight, while those who continued lost an additional 5.5%.
What is the lowest effective dose of a GLP-1?
It is the smallest dose that moves you toward your goal with side effects you can tolerate, and it differs from person to person. Many people respond well before reaching the highest available dose. Clinicians typically increase the dose gradually, which lowers the chance of nausea and other stomach side effects, and stop increasing once the response is good.
How does Bag Bar approach GLP-1 dosing?
Bag Bar's Metabolic Reset program is built around the lowest effective dose. Your PA-C starts low, increases gradually, adjusts for side effects and plans the maintenance phase from the beginning. Once you reach a plateau, we review whether a lower dose or a longer interval is reasonable based on your weight trend, labs and how you feel. Some patients may need ongoing dosing, and that is a medical decision made together, not a failure.
How can I reduce GLP-1 side effects?
Tell your clinician early. Common strategies include slower dose increases, smaller and lower-fat meals, adequate fluids and protein, and adjusting the dose or timing. Common side effects include nausea, vomiting, diarrhea and constipation. Seek care right away for severe or persistent abdominal pain, repeated vomiting or signs of dehydration.
Is reduced-frequency GLP-1 dosing FDA approved?
No. Weekly dosing is the FDA-approved schedule for semaglutide and tirzepatide products used for weight management. Stretching the interval is an emerging, investigational strategy that is not yet backed by randomized trials, so it should only be considered under the supervision of a licensed clinician.
Who should not take a GLP-1 medication?
GLP-1 medications are not appropriate for people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, or for people who are pregnant or planning pregnancy. Caution is needed with a history of pancreatitis, gallbladder disease or severe stomach and bowel conditions. A licensed clinician should review your history before you start.
Does Bag Bar offer GLP-1 weight loss care in Red Bank and Monmouth County, NJ?
Yes. Bag Bar's Metabolic Reset program offers semaglutide and tirzepatide through a licensed PA-C under physician medical director oversight, with house-call convenience across Monmouth County, including Red Bank, Rumson, Little Silver, Fair Haven, Colts Neck and Holmdel. The consultation fee is $150 and is credited toward your first month. Book through bagbariv.com/reservations.
About the author: Nadine, MS, PA-C, is the founder of Bag Bar, a PA-C-owned luxury mobile concierge IV therapy and wellness company based in Red Bank, NJ, operating under the supervision of a board-certified physician medical director.
This article is for educational purposes only and is not medical advice. Talk with a licensed healthcare provider before starting, changing or stopping any prescription medication. Individual results vary. All services are provided by a licensed PA-C under the supervision of Bag Bar's physician medical director.
Sources: Wong M, Wu A, Garhe P, Biermann M. Reduced-Frequency GLP1 Therapy Maintains Weight, Body Composition, and Metabolic Syndrome Improvements: A Case Series. Obesity, 2026 (PubMed) · Scripps Health, news release, March 3, 2026 (read it) · JAMA Network, Reduced-Frequency GLP-1 Dosing May Sustain Treatment Effects, 2026 (read it) · Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes, Obesity and Metabolism, 2022 (doi:10.1111/dom.14725) · Aronne LJ, Horn DB, Bays HE, et al. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial. JAMA, 2024;331(1):38-48 (PubMed) · Horn DB, et al. Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN). The Lancet, 2026
